Building on the radiosensitization capabilities of bismuth, Mishra et al. (2025) developed BiGd nanoparticles conjugated with anti-VEGF antibodies (aVEGF-BiGd) for targeted image-guided RT in hepatocellular carcinoma (HCC).103 These nanoconjugates displayed excellent biocompatibility and imaging capabilities while showing significant tumor reduction in RT-treated mouse models. Here, VEGFA is linked to hepatocellular carcinoma.